Revolutionizing Precision Medicines: AstraZenecas Acquisition of Fusion Pharmaceutical...
In a groundbreaking move, Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company renowned for its innovative next-generation radioconjugates (RCs) as precision medicines, has received shareholder...
May 29, 2024
• Biotechnology & Pharmaceuticals Industry
Products & Services
NASDAQ
